Insider trades

Argeris N. Karabelas, Director of Regenxbio RGNX, has filed 0 purchases and 8 sales on the open market. The latest trade was on 05/29.

Argeris N. Karabelas

Director
First filing
23/06/06
Trades
28 trades
Buys / sales
0 / 8
12-month net buying
No record
Last trade
05/29

Trading activity

Transactions

Trade type
Open-market sale10b5-1 plan24/10/0124/10/0210,000 sh$10.11$101,100−47.0%
RGNX
Open-market sale10b5-1 plan24/09/0324/09/0410,000 sh2 trades$11.56avg.$115,588−47.0%
RGNX
Open-market sale10b5-1 plan24/08/0124/08/0510,100 sh3 trades$13.51avg.$136,456−47.2%
Open-market sale10b5-1 plan24/07/2924/07/3011,000 sh$15.05$165,550−49.4%
Open-market sale10b5-1 plan24/07/0124/07/0310,000 sh$11.27$112,700−47.0%